definiens: shall have the meaning as defined in Section 10.1 ; 1.14 means [COMPANY] ’s manufacturing facilit y located at [COMPANY] Cell Manufacturing Facility B.V., Urmonderbaan 20b, 6167 RD Geleen, Th e Netherlands ; 1.15 means any a pplicable supra- national, federal, national, regional, state, provincial or local regulatory agencies, dep artments, bureaus, commissions, councils or other government entities regulating or otherwise exercis ing authority w ith respect to manufacture, use, transport ( including import and export ) or storage of the ImmunoCellular Materials or Product or the provision of the Services in any country ; 1.16 means the relevant party, its subsidia ries, Affiliates, its hold ing companies and their subsidiaries and Affiliates from time to time ; 1.17 means any and all information of what ever nature and in any form relating to either Party and their business affairs and all such other information relating to the ir [ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS D OCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24 B-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED